ALS antisense drug falters in phase III

Title
ALS antisense drug falters in phase III
Authors
Keywords
-
Journal
NATURE REVIEWS DRUG DISCOVERY
Volume 20, Issue 12, Pages 883-885
Publisher
Springer Science and Business Media LLC
Online
2021-10-29
DOI
10.1038/d41573-021-00181-w

Ask authors/readers for more resources

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started